Outcome (økonomiske)

Restrictive blood transfusion practices are associated with improved patient outcomes. (åbner nyt vindue)

Goodnough LT, Maggio P, Hadhazy E, Shieh L, Hernandez-Boussard T, Khari P, Shah N.

Kilde‎: Transfusion 2014;54(10 Pt 2):2753-9.

Indekseret‎: PubMed 24995770

DOI‎: 10.1111/trf.12723

https://www.ncbi.nlm.nih.gov/pubmed/24995770 (åbner nyt vindue)

Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. (åbner nyt vindue)

Leahy MF, Hofmann A, Towler S, Trentino KM, Burrows SA, Swain SG, Hamdorf J, Gallagher T, Koay A, Geelhoed GC, Farmer SL.

Kilde‎: Transfusion 2017;57(6):1347-58.

Indekseret‎: PubMed 28150313

DOI‎: 10.1111/trf.14006

https://www.ncbi.nlm.nih.gov/pubmed/28150313 (åbner nyt vindue)

Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients. (åbner nyt vindue)

MacLaren R, Sullivan PW.

Kilde‎: Value Health 2005;8(2):105-16.

Indekseret‎: PubMed 15804319

DOI‎: 10.1111/j.1524-4733.2005.04006.x

https://www.ncbi.nlm.nih.gov/pubmed/15804319 (åbner nyt vindue)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (åbner nyt vindue)

Mehra T, Seifert B, Bravo-Reiter S, Wanner G, Dutkowski P, Holubec T, Moos RM, Volbracht J, Manz MG, Spahn DR

Kilde‎: Transfusion 2015;55(12):2807-15.

Indekseret‎: PubMed 26264557

DOI‎: 10.1111/trf.13260

https://www.ncbi.nlm.nih.gov/pubmed/26264557 (åbner nyt vindue)

Trauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs. (åbner nyt vindue)

Nardi G, Agostini V, Rondinelli B, Russo E, Bastianini B, Bini G, Bulgarelli S, Cingolani E, Donato A, Gambale G, Ranaldi G

Kilde‎: Crit Care 2015;19:83.

Indekseret‎: PubMed 25880548

DOI‎: 10.1186/s13054-015-0817-9

https://www.ncbi.nlm.nih.gov/pubmed/25880548 (åbner nyt vindue)

The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. (åbner nyt vindue)

Roberts I, Shakur H, Coats T, Hunt B, Balogun E, Barnetson L, Cook L, Kawahara T, Perel P, Prieto-Merino D, Ramos M, Cairns J, Guerriero C.

Kilde‎: Health Technol Assess 2013;17(10):1-79.

Indekseret‎: PubMed 23477634

DOI‎: 10.3310/hta17100

https://www.ncbi.nlm.nih.gov/pubmed/23477634 (åbner nyt vindue)

Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma. (åbner nyt vindue)

Stein DM, Dutton RP, Kramer ME, Scalea TM.

Kilde‎: J Trauma 2009;66(1):63-72.

Indekseret‎: PubMed 19131807

DOI‎: 10.1097/TA.0b013e318191bc8a

https://www.ncbi.nlm.nih.gov/pubmed/19131807 (åbner nyt vindue)

Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulation. (åbner nyt vindue)

Zilberberg MD, Shorr AF.

Kilde‎: BMC Health Serv Res 2007;7:138.

Indekseret‎: PubMed 17764560

DOI‎: 10.1186/1472-6963-7-138

https://www.ncbi.nlm.nih.gov/pubmed/17764560 (åbner nyt vindue)

KRITISK SYGE OG INTENSIV BEHANDLING

Outcome (økonomiske)

Dansk

Outcome (økonomiske)

https://assetsnffrgf-a.akamaihd.net/assets/ct/d8f8c0370e/images/syn_placeholder_sqr.png

Restrictive blood transfusion practices are associated with improved patient outcomes. (åbner nyt vindue)

Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. (åbner nyt vindue)

Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients. (åbner nyt vindue)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (åbner nyt vindue)

Trauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs. (åbner nyt vindue)

The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. (åbner nyt vindue)

Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma. (åbner nyt vindue)

Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulation. (åbner nyt vindue)

Kontaktudvalg til Hospitaler (KUH)

Informationsmateriale til sundhedspersonale

Videoer

Outcome (økonomiske)

Vælg dit sprog

Del